Literature DB >> 10907475

Arsenicals and inhibitors of histone deacetylase as anticancer therapy.

R P Warrell1.   

Abstract

Mesh：

Substances：

Year:  1999        PMID： 10907475

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  5 in total

Review 1.  Epigenetics in acute myeloid leukemia.

Authors:  Christoph Plass; Christopher Oakes; William Blum; Guido Marcucci
Journal:  Semin Oncol       Date:  2008-08       Impact factor: 4.929

2.  Transcriptional induction of MKP-1 in response to stress is associated with histone H3 phosphorylation-acetylation.

Authors:  J Li; M Gorospe; D Hutter; J Barnes; S M Keyse; Y Liu
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

3.  Inhibitors of histone deacetylases target the Rb-E2F1 pathway for apoptosis induction through activation of proapoptotic protein Bim.

Authors:  Yan Zhao; Jing Tan; Li Zhuang; Xia Jiang; Edison T Liu; Qiang Yu
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-21       Impact factor: 11.205

4.  Activity of the yeast Tat2p tryptophan permease is sensitive to the anti-tumor agent 4-phenylbutyrate.

Authors:  Ming Liu; William S A Brusilow; Richard Needleman
Journal:  Curr Genet       Date:  2004-11       Impact factor: 3.886

5.  AURKA Suppresses Leukemic THP-1 Cell Differentiation through Inhibition of the KDM6B Pathway.

Authors:  Jin Woo Park; Hana Cho; Hyein Oh; Ji-Young Kim; Sang-Beom Seo
Journal:  Mol Cells       Date:  2018-02-23       Impact factor: 5.034
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.